| Literature DB >> 33642938 |
Xuan Li1, Shuxin Zhang1, Jiahua Shi1, Stephen P Luby2, Guangming Jiang1,3.
Abstract
Wastewater-based epidemiology (WBE) is a promising approach for estimating population-wide COVID-19 prevalence through detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA in wastewater. However, various methodological challenges associated with WBE would affect the accuracy of prevalence estimation. To date, the overall uncertainty of WBE and the impact of each step on the prevalence estimation are largely unknown. This study divided the WBE approach into five steps (i.e., virus shedding; in-sewer transportation; sampling and storage; analysis of SARS-CoV-2 RNA concentration in wastewater; back-estimation) and further summarized and quantified the uncertainties associated with each step through a systematic review. Although the shedding of SARS-CoV-2 RNA varied greatly between COVID-19 positive patients, with more than 10 infected persons in the catchment area, the uncertainty caused by the excretion rate became limited for the prevalence estimation. Using a high-frequency flow-proportional sampling and estimating the prevalence through actual water usage data significantly reduced the overall uncertainties to around 20-40% (relative standard deviation, RSD). And under such a scenario, the analytical uncertainty of SARS-CoV-2 RNA in wastewater was the dominant factor. This highlights the importance of using surrogate viruses as internal or external standards during the wastewater analysis, and the need for further improvement on analytical approaches to minimize the analytical uncertainty. This study supports the application of WBE as a complementary surveillance strategy for monitoring COVID-19 prevalence and provides methodological improvements and suggestions to enhance the reliability for future studies.Entities:
Keywords: COVID-19; Monte Carlo simulation; Prevalence estimation; SARS-CoV-2; Uncertainty; Wastewater-based epidemiology
Year: 2021 PMID: 33642938 PMCID: PMC7896122 DOI: 10.1016/j.cej.2021.129039
Source DB: PubMed Journal: Chem Eng J ISSN: 1385-8947 Impact factor: 13.273
Summary of literature search process.
| Target | Search terms | Number of unique papers identified through databases | Number of papers identified from references of review or other papers | Number of papers identified as relevant | Number of papers subjected to full text review | Number of papers included |
|---|---|---|---|---|---|---|
| SARS-CoV-2 excretion | “SARS-CoV-2” AND (“Stool” OR “Feces” OR “Urine”) | 685 | 0 | 57 | 54 | 33 |
| SARS-CoV-2 in wastewater | “SARS-CoV-2” AND (“Wastewater” OR “Water”) | 487 | 2 | 93 | 93 | 46 |
Equations used to back-calculate SARS-CoV-2 prevalence and assess effects of uncertainties.
| WBE processes | No. | WBE equations | Uncertainty equations |
|---|---|---|---|
| Viral load in sewers | B1 | ||
| Decay of SARS-CoV-2 | B2 | ||
| Excretion | B3 | ||
| Back-estimation | B4.1 | ||
| B4.2 |
Note: Eq. B1: L: the load of SARS-CoV-2 RNA detected in a sewer; C is the concentration of SARS-CoV-2 RNA detected in wastewater samples; F is the total wastewater flow during the sampling period; U, U and U are the uncertainty of L, sampling and flow measurement, respectively; U is the uncertainty of wastewater analysis, including concentration, RNA extraction, and detection. Eq. B2: D is the decay ratio of SARS-CoV-2 RNA in wastewater; C is the concentration of SARS-CoV-2 RNA excreted in wastewater before transportation in sewers; t is the traveling time of SARS-CoV-2 genome in wastewater, and k is the decay rate constant; U, U, and U are the uncertainties of D, k and t. Detailed explanation was included in Section 3.2. Eq. (B3): E is the excretion rate of SARS-CoV-2 RNA from infected people; Pop is the shedding probability of SARS-CoV-2 RNA in stools or urine of infected person; Q is the shedding mass quantity of stools or urine among the population; M is the virus shedding magnitude in stools or urine from infected person; U, U, and U are the uncertainty of shedding probability, quantity and magnitude, respectively. Eq. B4.1: P is the COVID-19 prevalence in the catchment area, P is the population size in the catchment area; U is the uncertainty of P. Eq. B4.2: Q is the daily amount of water usage, and U is its uncertainty.
Statistics of the shedding probability and magnitude.
| Urine shedding probability | Stool shedding probability | Stool shedding magnitude (log10 copies/g) | |
|---|---|---|---|
| Mean | 0.026 | 0.545 | 4.523 |
| Standard deviation | 0.030 | 0.093 | 0.133 |
| Median | 0.018 | 0.544 | 4.523 |
| 95% CI | 6.3 × 10-4- 0.10 | 0.37–0.73 | 4.26–4.78 |
Sampling practice and preservation techniques from current available publications.
| Area/Country a | Sampling location | Sampling technique | Sample type | Results b | Preservation temperature, period | Reference |
|---|---|---|---|---|---|---|
| Queensland, Australia | WWTP and Pumping station | Grab and composite sampling (24 h) | Influent | 2/9 | 4 °C, n.m. c | |
| Queensland, Australia | WWTP | Grab and composite sampling (24 h) | Influent | 19/63 | 4 °C, n.m. | |
| Australia | Commercial passenger aircraft | Grab sampling | Treated aircraft wastewater | 1/3 | 4 °C, within 6–24 h | |
| Cruise ship | Raw wastewater | 1/1 | ||||
| Effluent of membrane bioreactor | 1/1 | |||||
| Niteroi, Brazil | WWTP | Composite sampling (10 h) | Influent | 0/2 | n.m. | |
| Hospital | 3/8 | |||||
| Sewer | 2/2 | |||||
| Zhejiang, China | Hospital | n.m. | Influent of pre-processing disinfection pool in hospital | 3/3 | n.m. | |
| Effluent of hospital wastewater from pre-processing disinfection pool | 1/1 | |||||
| Final effluent of hospital wastewater | 0/1 | |||||
| Wuhan, China | Hospital | n.m. | Influent of septic tank | 7/9 | 4 °C, processed immediately | |
| Effluent of septic tank | 0/4 | |||||
| Czech Republic | WWTP | Composite sampling (24 h) | Influent | 13/112 | 5 ± 3 °C, within 48 h | |
| Quito, Ecuador | River | Grab sampling | River water receiving raw wastewater | 3/3 | 4 °C, less than 3 h | |
| Montpellier, France | WWTP | Composite sampling (24 h) | Influent | 3/12 | −20 °C, n.m. | |
| Thessaloniki, Greece | WWTP | Composite sampling (24 h) | Influent | 16/29 | 4 °C, within 24 h | |
| Gujarat, India | WWTP | Composite sampling (3 days) | Influent | 6/6 | 4 °C, within 20 days | |
| Effluent | 0/6 | |||||
| Gujarat, India | WWTP | Composite sampling (3 days) | Influent | 4/6 | 4 °C, within 20 days | |
| Effluent | 0/6 | |||||
| A upflow anaerobic sludge blanket (UASB) | Influent of UASB | 3/6 | ||||
| Effluent of UASB | 3/6 | |||||
| Jaipur, India | WWTP | Grab sampling | Influent | 6/17 | n.m. | |
| Effluent | 0/8 | |||||
| Stockholm, Sweden | WWTP | n.m. | Influent | 4/6 | 4 °C, within 24 h | |
| North of Italy | 1/4 | Delivered to the laboratory on dry ice, stored at − 20 °C, n.m. | ||||
| Italy | WWTP | Composite sampling (24 h) | Influent | 6/12 | −20 °C, n.m. | |
| Italy | WWTP | Grab sampling | Influent | 4/8 | Under refrigeration, n.m. | |
| Effluent | 0/4 | |||||
| River | River water | 3/4 | ||||
| Italy | WWTP | Composite sampling (24 h) | Influent | 26/40 | −20 °C, n.m. | |
| Italy | WWTP and pumping stations | Grab sampling | Influent | 4/9 | 4 °C, processed immediately and also after 24 h | |
| Effluent | 2/2 | |||||
| Japan | WWTP | Grab sampling | Influent | 0/5 | On ice, processed within 6 h of collection | |
| Effluent from secondary treatment | 1/5 | |||||
| River | River water | 0/3 | ||||
| Tokyo, Japan | WWTP | Grab sampling | Influent | 4/12 | −20 °C, n.m. | |
| Japan | WWTP | Grab sampling | Influent | 21/45 | Four samples, −20 °C, n.m. | |
| Japan | Manholes and WWTP | Grab sampling | Supernatant of raw wastewater | 6/32 | −20 °C, within 10 days. | |
| Solids of raw wastewater | 18/32 | |||||
| Slovenia | Pumping station of a hospital | Composite sampling (24 h) | Raw wastewater | 10/15 | −70 °C, n.m. | |
| Sweden | WWTP | Composite sampling (24 h) | Influent | 18/21 | −20 °C, n.m. | |
| Effluent | 13/21 | |||||
| Sewer sampling station | 0.5L wastewater per day for 4 days | Raw wastewater | 15/20 | |||
| Valencia, Spain | WWTP | Grab sampling | Influent | 12/12 | 4 °C, n.m. | |
| Murcia, Spain | WWTP | Grab sampling | Influent | 35/42 | 4 °C, less than 24 h | |
| Effluent from secondary treatment | 2/18 | |||||
| Effluent from tertiary treatment | 0/12 | |||||
| The Netherlands | WWTP | Composite sampling (24 h) | Influent | 10/21 | 4 °C, processed on the day of sampling | |
| South East England, UK | WWTP | Composite sampling (24 h) | Influent | 3/5 | −80 °C, n.m. | |
| Louisiana, USA | WWTP | Composite sampling (24 h) | Influent | 1/3 | −80 °C, within 6 h | |
| Effluent from secondary treatment | 0/3 | |||||
| Effluent | 0/3 | |||||
| Grab sampling | Influent | 1/4 | ||||
| Effluent from secondary treatment | 0/1 | |||||
| Effluent | 0/1 | |||||
| Virginia, USA | WWTP | Composite sampling (24 h) and grab sampling | Influent | 98/198 | On ice, within 6 h | |
| Massachusetts, USA | WWTP | Composite sampling (24 h) | Influent | 10/14 | 4 °C, n.m. | |
| Montana, USA | WWTP | Grab and composite sampling (24 h) | Influent | 7/7 | 4 °C, n.m. | |
| New York, USA | WWTP | Composite sampling (24 h) | Influent | 5/9 | −20 °C, n.m. | |
| Nevada, USA | WWTP | Grab and composite sampling (24 h) | Influent | 46/46 | n.m. | |
| Secondary effluent | 0/4 | |||||
| Finished effluent | 0/2 | |||||
| Natural lakes | Grab sampling | Lake water | 0/22 | |||
| Drinking water | Grab sampling | Finished drinking water from a treatment plant | 0/33 | |||
| California, USA | WWTP | Composite sampling (24 h) | Influent | 1/12 | −20 °C, n.m. | |
| Composite sampling (24 h) and grab sampling | Settled solids samples from primary settler | 9/17 | −80 °C, n.m. | |||
| Seattle, USA | WWTP | Grab sampling | Primary composite sludge | 12/17 | 4 °C, within one week | |
| Influent | 22/45 | |||||
| Dubai, UAE | Pumping stations and WWTP | Grab sampling | Influent | 829/2900 | n.m. | |
| Commercial aircraft | Raw wastewater | 27/198 | ||||
| UAE | Pumping stations, manholes | Grab samples | Raw wastewater | 85% | Preserved on ice, and transported to a laboratory, n.m. | |
| WWTP | Composite sampling (24 h) | Influent | ||||
| Effluent | 0% |
Note:
a: Sorted based on alphabetical order of countries.
b: Results are presented as number of SARS-CoV-2 RNA positive samples/number of total samples tested.
c: n.m. not mentioned.
Concentration methods and recovery efficiency in wastewater samples.
| Concentration | Extraction methods | Detection method | Virus | Recovery efficiency | Uncertainty (RSD) | Reference | |
|---|---|---|---|---|---|---|---|
| Methods | Consumables | ||||||
| Adsorption-elution method | Electronegative membrane (EMB) | RNeasy PowerMicrobiome Kit with glass beads replaced with garnet beads | RT-qPCR | MHV | 60.5 ± 22.2% | 0.37 | |
| EMB/Acidification of sample to pH 4 | MHV | 26.7 ± 15.3% | 0.57 | ||||
| EMB/Addition of MgCl2 | MHV | ||||||
| EMB | NucliSENS easyMag (bioMerieux, Inc., Durham, NC, USA) | RT-ddPCR | BCoV | 4.8 ± 2.8% | 0.58 | ||
| BRSV | 6.6 ± 3.8% | 0.58 | |||||
| QIAamp Viral RNA Mini Kit | RT-qPCR | MS2 | 1.0%-9.5% | N/Aa | |||
| φ6 | 1.6%-21.0% | ||||||
| Acid guanidinium thiocyanate–phenol–chloroform extraction using TRIzol reagent (TRIzol) | MS2 | 0.3% − 4.6% | |||||
| φ6 | 0.5% − 2.8% | ||||||
| Ultrafiltration | Amicon® Ultra-15 (30 K) Centrifugal Filter Devices | RNeasy PowerMicrobiome Kit with glass beads replaced with garnet beads | RT-qPCR | MHV | 56.0 ± 32.3% | 0.58 | |
| Centricon Plus-70 centrifugal filter with a molecular weight cut-off of 10 kDa | MHV | 28.0 ± 9.10% | 0.33 | ||||
| RNeasy PowerMicrobiome Kit | RT-qPCR | F-specific RNA phages | 73 ± 50% | 0.68 | |||
| Centricon Plus-70 centrifugal device with a molecular weight cutoff of 30 kDa | QIAamp Viral RNA Mini Kit | RT-qPCR | MS2 | 16.5% − 27.6% | N/A | ||
| φ6 | 6.4% − 35.8% | ||||||
| TRIzol | MS2 | 5.2% − 8.4% | |||||
| φ6 | 13.8% − 30% | ||||||
| Hollow fiber ultrafiltration | Purelink Viral RNA/DNA Mini Kit | RT-qPCR | BCoV | 54 ± 11% | 0.20 | ||
| PMMoV | 4.0 ± 2.2% | 0.55 | |||||
| Centricon Plus-70, 30 kDa or 100 kDa | BCoV | 55 ± 38% | 0.69 | ||||
| PMMoV | 1.3 ± 0.16% | 0.12 | |||||
| 30 kDa AMICON® Ultra-15 Centrifugal Filters. | QIAamp® Viral RNA Mini Kit | RT-qPCR | SARS-CoV-2 | 51.4 ± 12.6%, 38.8 ± 11.6% b | 0.25, 0.30b | ||
| 10 kDA AMICON® Ultra-15 Centrifugal Filters. | 48.6 ± 41.6%, 49.5 ± 25.0% b | 0.86, 0.51b | |||||
| Precipitation | Aluminum hydroxide adsorption-precipitation | NucleoSpin RNA virus kit | RT-qPCR | PEDV | 11 ± 3.5% | 0.32 | |
| MgV | 11 ± 2.1% | 0.19 | |||||
| 2.56%–18.78% | N/A | ||||||
| Direct-zol RNA Miniprep (Zymo Research) Kit | RT-qPCR | FCV | 45.0 ± 19.2% | 0.43 | |||
| Maxwell® RSC 48 Extraction System (Promega) | SARS-CoV-2 | 7.4 ± 7.9% −9.4 ± 14.7% | 1.07–1.56 | ||||
| Maxwell® RSC Instrument | RT-qPCR | SARS-CoV-2 | 30.2 ± 17.7% | 0.59 | |||
| MgV | 6.8 ± 4.8% | 0.71 | |||||
| PEG/NaCl | NucliSENS® miniMAG® semi-automated extraction system | RT-qPCR | HCoV-229E | 2.04 ± 0.7% | 0.34 | ||
| RNeasy PowerMicrobiome Kit with glass beads replaced with garnet beads | RT-qPCR | MHV | 44.0 ± 27.7% | 0.63 | |||
| Direct-zol RNA Miniprep (Zymo Research) Kit | RT-qPCR | FCV | 62.2 ± 30.8% | 0.50 | |||
| Maxwell® RSC 48 Extraction System (Promega) | SARS-CoV-2 | 38.8 ± 46.5% | 1.19 | ||||
| QIAamp Viral RNA Mini Kit | RT-qPCR | MS2 | 27.0% − 51.4% | N/A | |||
| φ6 | 1.4% − 3.0% | ||||||
| TRIzol | MS2 | 27.5% − 77.6% | |||||
| φ6 | 29.8% − 49.8% | ||||||
| Purelink Viral RNA/DNA Mini Kit | RT-qPCR | BCoV | 11 ± 8.4% | 0.76 | |||
| PMMoV | 0.28 ± 0.10% | 0.36 | |||||
| Nucleospin RNA virus Kit | RT-qPCR | SARS-CoV-2 | 52.8 ± 18.2% | 0.34 | |||
| MgV | 11.1 ± 4.9% | 0.44 | |||||
| Beef extract solution | NucliSENS® miniMAG® system | RT-qPCR | TGEV | 35.5 ± 13.0% | 0.37 | ||
| Ultracentrifugation | 0.25 N glycine buffer (pH 9.5) | RNeasy PowerMicrobiome Kit with glass beads replaced with garnet beads | RT-qPCR analyses | MHV | 33.5 ± 12.1% | 0.36 | |
| Direct Extraction | Without concentration | NucliSENS® easyMag® system | RT-ddPCR | BCoV | 59% ± 14% | 0.24 | |
| BRSV | |||||||
| InnovaPrep (with centrifugation) | 0.05 μm PS Hollow Fiber concentrating pipette tip on the InnovaPrep Concentrating Pipette Select | BCoV | 5.5% ±2.1% | 0.38 | |||
| BRSV | 7.6% ±3.0% | 0.39 | |||||
Note:
a: Not applicable.
b: Defined using two RT-qPCR assay targets.
PEG: Polyethylene glycol; MHV, Mouse hepatitis virus; BCoV, Bovine coronavirus; BRSV, Bovine respiratory syncytial virus; MS2, Bacteriophage MS2; φ6: Pseudomonas phage φ6; PEDV: Porcine epidemic diarrhea virus; MgV: Mengovirus; HCoV-229E, human coronavirus 229E; FCV, Feline calicivirus; PMMoV, Pepper mild mottle virus; TGEV, Transmissible gastroenteritis coronavirus; RT-ddPCR: Reverse transcription droplet digital PCR.
Uncertainty values (RSD) related to the prevalence of COVID-19 through WBE back-estimation.
| Back estimation | Sampling | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T4.1 | composite | 5 | 17–36 | 20 | – | 5–11 | 20 | 16 | 37–50 | 32–46 | 32–46 | 32–46 |
| grab | 30 | 17–36 | 20 | – | 5–11 | 20 | 16 | 44–56 | 40–52 | 40–52 | 40–52 | |
| T4.2 | composite | 5 | 17–36 | – | 10 | 5–11 | 20 | – | 29–44 | 22–40 | 21–40 | 21–40 |
| grab | 30 | 17–36 | – | 10 | 5–11 | 20 | – | 41–53 | 37–50 | 36–49 | 36–49 | |